Ultralife Corporation (ULBI)
Ultralife Statistics
Share Statistics
Ultralife has 16.63M shares outstanding. The number of shares has increased by 0.03% in one year.
| Shares Outstanding | 16.63M |
| Shares Change (YoY) | 0.03% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 37.74% |
| Shares Floating | 10.13M |
| Failed to Deliver (FTD) Shares | 9 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 316.9K, so 1.91% of the outstanding shares have been sold short.
| Short Interest | 316.9K |
| Short % of Shares Out | 1.91% |
| Short % of Float | 8.08% |
| Short Ratio (days to cover) | 6.81 |
Valuation Ratios
The PE ratio is 19.54 and the forward PE ratio is null. Ultralife's PEG ratio is -1.43.
| PE Ratio | 19.54 |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| Forward PS | 0.3 |
| PB Ratio | 0.92 |
| P/FCF Ratio | 8.39 |
| PEG Ratio | -1.43 |
Enterprise Valuation
Ultralife has an Enterprise Value (EV) of 119.23M.
| EV / Sales | 0.73 |
| EV / EBITDA | 8.28 |
| EV / EBIT | 7.17 |
| EV / FCF | 8.11 |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.32 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.19 |
| Interest Coverage | 5.14 |
Financial Efficiency
Return on Equity is 4.71% and Return on Invested Capital is 3.97%.
| Return on Equity | 4.71% |
| Return on Assets | 2.86% |
| Return on Invested Capital | 3.97% |
| Revenue Per Employee | $306.82K |
| Profits Per Employee | $11.78K |
| Employee Count | 536 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | 1.89M |
| Effective Tax Rate | 22.79% |
Stock Price Statistics
The stock price has increased by -51.42% in the last 52 weeks. The beta is 0.98, so Ultralife's price volatility has been higher than the market average.
| Beta | 0.98 |
| 52-Week Price Change | -51.42% |
| 50-Day Moving Average | 5.8 |
| 200-Day Moving Average | 8.22 |
| Relative Strength Index (RSI) | 32.5 |
| Average Volume (20 Days) | 59.06K |
Income Statement
In the last 12 months, Ultralife had revenue of 164.46M and earned 6.31M in profits. Earnings per share was 0.38.
| Revenue | 164.46M |
| Gross Profit | 42.31M |
| Operating Income | 9.96M |
| Net Income | 6.31M |
| EBITDA | 14.4M |
| EBIT | 10.24M |
| Earnings Per Share (EPS) | 0.38 |
Balance Sheet
The company has 6.85M in cash and 2.75M in debt, giving a net cash position of 4.1M.
| Cash & Cash Equivalents | 6.85M |
| Total Debt | 2.75M |
| Net Cash | 4.1M |
| Retained Earnings | -34.44M |
| Total Assets | 220.45M |
| Working Capital | 67.87M |
Cash Flow
In the last 12 months, operating cash flow was 16.64M and capital expenditures -1.93M, giving a free cash flow of 14.7M.
| Operating Cash Flow | 16.64M |
| Capital Expenditures | -1.93M |
| Free Cash Flow | 14.7M |
| FCF Per Share | 0.89 |
Margins
Gross margin is 25.73%, with operating and profit margins of 6.06% and 3.84%.
| Gross Margin | 25.73% |
| Operating Margin | 6.06% |
| Pretax Margin | 5.05% |
| Profit Margin | 3.84% |
| EBITDA Margin | 8.75% |
| EBIT Margin | 6.06% |
| FCF Margin | 8.94% |
Dividends & Yields
ULBI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 5.12% |
| FCF Yield | 11.92% |
Analyst Forecast
The average price target for ULBI is $14, which is 227.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 227.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 4 |